In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil

European Urology

Volumn 60, Issue 5, 2011, Pages 1074-1080

  Kobus, Thiele ^a   Hambrock, Thomas ^a   Hulsbergen Van De Kaa, Christina A ^a   Wright, Alan J ^a   Barentsz, Jelle O ^a   Heerschap, Arend ^a   Scheenen, Tom W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Metabolite ratios; MR spectroscopic imaging; Prostate cancer aggressiveness

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE;

ADULT; AGED; ARTICLE; CANCER AGGRESSIVENESS; CANCER GRADING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; VALIDATION STUDY;

ADULT; AGED; BIOPSY; CHOLINE; CITRIC ACID; CREATINE; EQUIPMENT DESIGN; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 80053086913     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.03.002     Document Type: Article

References (30)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. F.H. Schröder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
3. S. Tomioka, H. Nakatsu, N. Suzuki, S. Murakami, O. Matsuzaki, and J. Shimazaki Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer Int J Urol 13 2006 555 559 (Pubitemid 43760419)
4. A. Rajinikanth, M. Manoharan, C.T. Soloway, F.J. Civantos, and M.S. Soloway Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years Urology 72 2008 177 182
5. T.W. Scheenen, D.W. Klomp, S.A. Roll, J.J. Futterer, J.O. Barentsz, and A. Heerschap Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate Magn Reson Med 52 2004 80 88 (Pubitemid 39295259)
6. T.W. Scheenen, S.W. Heijmink, and S.A. Roell Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility Radiology 245 2007 507 516 (Pubitemid 47612533)
7. 3) spatial resolution Radiology 198 1996 795 805 (Pubitemid 26066301)
8. A. Heerschap, G.J. Jager, and M. Van Der Graaf In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue Anticancer Res 17 1997 1455 1460 (Pubitemid 27257633)
9. G.M. Villeirs, G.O. De Meerleer, P.J. De Visschere, V.H. Fonteyne, A.C. Verbaeys, and W. Oosterlinck Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients Eur J Radiol 77 2011 340 345
10. J. Kurhanewicz, D.B. Vigneron, R.G. Males, M.G. Swanson, K.K. Yu, and H. Hricak The prostate: MR imaging and spectroscopy: present and future Radiol Clin North Am 38 2000 115 138 (Pubitemid 30059008)
11. K.L. Zakian, K. Sircar, and H. Hricak Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy Radiology 234 2005 804 814 (Pubitemid 40250824)
12. I. Jambor, R. Borra, and J. Kemppainen Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy J Nucl Med 51 2010 1676 1683
13. E. Ackerstaff, B.R. Pflug, J.B. Nelson, and Z.M. Bhujwalla Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells Cancer Res 61 2001 3599 3603 (Pubitemid 32694969)
14. J.A. Jung, F.V. Coakley, and D.B. Vigneron Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system Radiology 233 2004 701 708
15. J.J. Fütterer, T.W.J. Scheenen, and Heijmink SWTPJ Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate Invest Radiol 42 2007 116 122 (Pubitemid 46104892)
16. J.J.A. Van Asten, V. Cuijpers, and C. Hulsbergen-Van De Kaa High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies MAGMA 21 2008 435 442
17. T.W.J. Scheenen, G. Gambarota, and E. Weiland Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T Magn Reson Med 53 2005 1268 1274 (Pubitemid 40734645)
18. R. Pohmann, and M. von Kienlin Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI Magn Reson Med 45 2001 817 826 (Pubitemid 32402024)
19. I.M. Van Oort, H.M. Bruins, L.A.L.M. Kiemeney, B.C. Knipscheer, J.A. Witjes, and C.A. Hulsbergen-Van De Kaa The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy Histopathology 56 2010 464 471
20. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 2005 1228 1242 (Pubitemid 41232997)
21. F.L. Greene, D.L. Page, and I.D. Flemming AJCC cancer staging manual ed. 6 2002 Springer-Verlag New York
22. H. Augustin, P.G. Hammerer, and M. Graefen Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction Eur Urol 43 2003 455 460 (Pubitemid 36528428)
23. T.A. Stamey, F.S. Freiha, J.E. McNeal, E.A. Redwine, A.S. Whittemore, and H.P. Schmid Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 71 1993 933 938 (Pubitemid 23049614)
24. C.E. Metz, B.A. Herman, and C.A. Roe Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets Med Decis Making 18 1998 110 121 (Pubitemid 28041647)
25. G.L. Andriole, E.D. Crawford, and R.L. Grubb III Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
26. M. Seitz, A. Shukla-Dave, and A. Bjartell Functional magnetic resonance imaging in prostate cancer Eur Urol 55 2009 801 814
27. T.Y. Chan, A.W. Partin, P.C. Walsh, and J.I. Epstein Prognostic significance of Gleason score 3 + 4 versus Gleason score 4 + 3 tumor at radical prostatectomy Urology 56 2000 823 827
28. E.M. Hattab, M.O. Koch, J.N. Eble, H. Lin, and L. Cheng Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma J Urol 175 2006 1695 1699
29. C.A. Mosse, C. Magi-Galluzzi, T. Tsuzuki, and J.I. Epstein The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens Am J Surg Pathol 28 2004 394 398 (Pubitemid 38269575)
30. C.C. Pan, S.R. Potter, A.W. Partin, and J.I. Epstein The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system Am J Surg Pathol 24 2000 563 569 (Pubitemid 30180750)